A Review of Rare Disease Policies and Orphan Drug Reimbursement Systems in 12 Eurasian Countries-Reference-Cited by-同舟云学术

A Review of Rare Disease Policies and Orphan Drug Reimbursement Systems in 12 Eurasian Countries

Published:2020-01-28 Issue: Volume:7 Page:
ISSN:2296-2565
Container-title:Frontiers in Public Health
language:
Short-container-title:Front. Public Health

Author:

Czech Marcin,Baran-Kooiker Aleksandra,Atikeler Kagan,Demirtshyan Maria,Gaitova Kamilla,Holownia-Voloskova Malwina,Turcu-Stiolica Adina,Kooiker Coen,Piniazhko Oresta,Konstandyan Natella,Zalis'ka Olha,Sykut-Cegielska Jolanta

Publisher

Frontiers Media SA

Subject

Public Health, Environmental and Occupational Health

Reference120 articles.

1. European Medicines Agency: Annual Report on the Use of the Special Contribution for Orphan Medicinal Products2018

2. Orphanet Report Series, Lists of Medicinal Products for Rare Diseases in Europe2018

3. Orphan Medicines Figures 2000-20182018

4. Regulation (EC) No 726/2004 of the European Parliament and of the Council of 31 March 2004 Laying Down Community Procedures for the Authorisation and Supervision of Medicinal Products for Human and Veterinary use and Establishing a European Medicines Agency

5. Do payers value rarity?;Medic;J Mark Access Health Policy,2017

Cited by 66 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Operational description of rare diseases: a reference to improve the recognition and visibility of rare diseases;Orphanet Journal of Rare Diseases;2024-09-11

2. HTA criteria adopted in different models of public healthcare systems for orphan drugs: A scoping review;Health Policy;2024-06

3. Availability and Access to Orphan Drugs for Rare Cancers in Bulgaria: Analysis of Delays and Public Expenditures;Cancers;2024-04-12

4. Challenges in public policy for the implementation of pharmacogenetic tests in Europe;BioSocieties;2024-03-16

5. Review of methods for estimating the prevalence of rare diseases;Rare Disease and Orphan Drugs Journal;2024-02-18